Combined stent retriever and contact aspiration improves first-line recanalisation but not clinical outcomes: a pooled analysis of the ASTER, ASTER2, and VECTOR trials.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Marnat Gaultier, Lapergue Bertrand, Piotin Michel, Labreuche Julien, Dargazanli Cyril, Desal Hubert, Gory Benjamin, Zhu François, Rouchaud Aymeric, Consoli Arturo, Shotar Eimad, Caroff Jildaz, Eugene François, Desilles Jean-Philippe, Janot Kevin, Boulouis Gregoire, Gentric Jean-Christophe, L'Allinec Vincent, Clarençon Frédéric, Kerleroux Basile, Pop Raoul, Soize Sébastien, Mazighi Mikael, Bourdain Frédéric, Richter Sebastian, Houdart Emmanuel, Bricout Nicolas, Barreau Xavier, Blanc Raphael, Bourcier Romain
Аннотация
PATIENTS AND METHODS: This retrospective analysis combines individual patient data from 3 large multicenter, RCTs: ASTER, ASTER2, and VECTOR. The primary outcome was the proportion of patients who achieved favourable recanalisation (defined as a modified Thrombolysis in Cerebral Infarction score of 2b, 2c or 3) after the first-line treatment, without a second-line rescue technique. Secondary outcomes included the first pass effect, disability assessed by the 90-day modified Rankin Scale (mRS) score, 24-hour change in National Institutes of Health Stroke Scale (NIHSS), 90-day all-cause mortality, and serious procedure-related adverse events.
RESULTS: Among 1,185 included patients, 434 received the combined approach, 414 received CA alone, and 337 received SR alone. Baseline characteristics were similar among groups. After adjusting for factors using propensity score weighting, the primary outcome was achieved more often in the combined group compared to CA alone (risk ratio = 1.95; 95% CI, 1.42 to 2.68; P < 0.001) or SR alone (Odds ratio = 1.70; 95% CI, 1.21 to 2.38; P = .002). There were no significant differences in 24-hour change in NIHSS, 90-day mRS, or adverse events among the groups.
CONCLUSIONS: In this pooled analysis of 3 RCTs, the combined approach as the first-line treatment for anterior circulation LVO increased the probability of achieving favourable recanalisation without the need for a second-line approach, compared to CA or SR alone but no impact on clinical outcomes was detected.